| Date | Announcement | Attachment |
|---|---|---|
| Mar 1, 2010 | Expiry of HIV Integrase Option Period with Tibotec |
|
| Feb 15, 2010 | Avexa reports positive phase IIb 144 week data for HIV drug apricitabine |
|
| Feb 4, 2010 | Avexa announces ATC phase III top line results |
|